Susan Kelley
Director/Board Member at IDEAYA BIOSCIENCES, INC.
Net worth: - $ as of 2024-03-30
Profile
Susan L.
Kelley is currently serving as a Director at Deciphera Pharmaceuticals LLC, Independent Director at IDEAYA Biosciences, Inc., Independent Director at Daré Bioscience, Inc., Independent Director at Deciphera Pharmaceuticals, Inc., and Director at A2 Biotherapeutics, Inc. She has previously served as an Independent Director at ArQule, Inc., Independent Non-Executive Director at The Sustainable Nutrition Group Pty Ltd., Director at Audeo Oncology, Inc., Independent Director at Cerulean Pharma, Inc., Executive Director-Oncology Clinical Research at Bristol-Myers Squibb World Wide Medicines Group, Executive Director-Oncology Clinical Research at Bristol-Myers Squibb Pharmaceutical Research Institute, Independent Non-Executive Director at Vascular Biogenics Ltd., Independent Director at Immune Design Corp., Executive Director at Oncology Clinical Research & Development, Vice President-Global Clinical Development at Bayer Schering Pharma AG, Vice President-Global Clinical Development at Bayer Pharma AG, Chief Medical Officer at The Multiple Myeloma Research Foundation, Inc., Vice President-Global Clinical Development at Bayer HealthCare Pharmaceuticals, Inc., Chief Medical Officer at Multiple Myeloma Research Consortium, and Assistant Professor at Yale School of Medicine.
She completed her undergraduate degree from Colgate University and her doctorate from Duke University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
DARE BIOSCIENCE, INC.
-.--% | 2023-06-20 | 0 ( -.--% ) | - $ | 2024-03-30 |
| 2023-06-20 | 0 ( -.--% ) | - $ | 2024-03-30 | |
IDEAYA BIOSCIENCES, INC.
-.--% | 2023-06-06 | 0 ( -.--% ) | - $ | 2024-03-30 |
Susan Kelley active positions
| Companies | Position | Start |
|---|---|---|
| DARÉ BIOSCIENCE, INC. | Director/Board Member | 2014-09-30 |
| DECIPHERA PHARMACEUTICALS, INC. | Director/Board Member | 2019-07-07 |
| IDEAYA BIOSCIENCES, INC. | Director/Board Member | 2021-02-16 |
Deciphera Pharmaceuticals LLC
 Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Director/Board Member | 2019-06-30 |
A2 Biotherapeutics, Inc.
 A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services A2 Biotherapeutics, Inc. operates as a biotechnology company. It develops medicines. The company was founded by Alexander Kamb, Michael Gallo and Paul Kang in 2018 and is headquartered in Westlake Village, CA. | Director/Board Member | - |
Former positions of Susan Kelley
| Companies | Position | End |
|---|---|---|
| ARQULE, INC. | Director/Board Member | 2020-01-15 |
| NOTABLE LABS, LTD. | Director/Board Member | 2019-12-31 |
| IMMUNE DESIGN CORP | Director/Board Member | 2019-04-01 |
Cerulean Pharma, Inc.
 Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Director/Board Member | 2016-12-31 |
| ░░░ ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Susan Kelley
| Colgate University | Undergraduate Degree |
| Duke University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| IDEAYA BIOSCIENCES, INC. | Health Technology |
| DARÉ BIOSCIENCE, INC. | Health Technology |
| DECIPHERA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 16 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
| Bayer Schering Pharma AG | Health Technology |
The Sustainable Nutrition Group Pty Ltd.
 The Sustainable Nutrition Group Pty Ltd. Agricultural Commodities/MillingProcess Industries The Sustainable Nutrition Group Ltd. produces, manufactures, and distributes a range of hemp products in Australia. It is involved in hemp seed selection, farming, processing, and packaging, as well as distribution and sale of bulk and retail products. The company's products include hand sanitizers, hemp oils, hemp seeds, hemp protein powders, and hemp flour under the APH and Mt Elephant brands to retail, wholesale, and white label customers. The company was founded by James Hood and Tracie Rams dale in 1995 and is headquartered in Newtown, Australia. | Process Industries |
Audeo Oncology, Inc.
 Audeo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Audeo Oncology, Inc. used to provide cancer treatment services. It focused on utilizing its Hyaluronic Acid Chemotransport technology for cancer drugs and tumor cells to enhance drug activities. The company was founded on June 1, 2012 and was headquartered in San Francisco, CA. | Health Technology |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Health Technology |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Health Technology |
The Multiple Myeloma Research Foundation, Inc.
 The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT. | Commercial Services |
Bristol-Myers Squibb World Wide Medicines Group
 Bristol-Myers Squibb World Wide Medicines Group Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb World Wide Medicines Group manufactures pharmaceutical products. The private company is based in Lawrenceville, NJ. | Health Technology |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | Health Technology |
Multiple Myeloma Research Consortium
 Multiple Myeloma Research Consortium Miscellaneous Commercial ServicesCommercial Services Multiple Myeloma Research Foundation, the mission of the MMRF is to accelerate the development of novel and combination treatments for patients with multiple myeloma by promoting and facilitating collaborative research between industry and academia. The MMRC is led by an exceptional Leadership Team, including a full scientific and clinical staff, which is headquartered in Norwalk, Conn | Commercial Services |
| Bristol-Myers Squibb Pharmaceutical Research Institute | |
Vascular Biogenics Ltd.
 Vascular Biogenics Ltd. BiotechnologyHealth Technology Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. | Health Technology |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
Deciphera Pharmaceuticals LLC
Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Health Technology |
| Oncology Clinical Research & Development | |
A2 Biotherapeutics, Inc.
A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services A2 Biotherapeutics, Inc. operates as a biotechnology company. It develops medicines. The company was founded by Alexander Kamb, Michael Gallo and Paul Kang in 2018 and is headquartered in Westlake Village, CA. | Commercial Services |
- Stock Market
- Insiders
- Susan Kelley
